MAP2 and schizophrenia: We have previously shown that MAP2 is hyperphosphorylated in schizophrenia (SZ), with phosphorylation at serine 1782 (S1782) being increased ~7-fold in schizophrenia subjects compared to non-psychiatric controls (Grubisha et al., 2021).